DJIA 15,660.18 -254.56 -1.60%
NASDAQ 4,266.84 -16.76 -0.39%
S&P 500 1,829.08 -22.78 -1.23%
market minute promo

244.04 -5.89 (-2.36%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

IBB $244.04 -2.36%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $242.95
Previous Close $249.93
Daily Range $240.55 - $246.25
52-Week Range $240.03 - $400.79
Market Cap $5.9B
P/E Ratio -1,086.65
Dividend (Yield) $0.13 (0.0%)
Ex-Dividend Date
Dividend Pay Date
Volume 2,791,105
Average Daily Volume 2,991,487
Current FY EPS $0.00




Financial Services

iShares NASDAQ Biotechnology Index (ETF) (IBB) Description

The investment seeks investment results that correspond generally to the price and yield performance before fees and expenses of the NASDAQ Biotechnology Index (the underlying index). Website:

News & Commentary

Why Biogen Inc.'s Stock Sank in January

Biogen's slowing growth has investors looking towards the future.

Biotechnology ETF (IBB) Trend Reversal, Is The Bottom In?

The March To March - Stand Down Yellen

Why Investors Could Be Disappointed With Janet Yellen's Testimony

3 Biotech Stocks to Buy in a Market Crash

Gilead Sciences, Celgene Corp, and Regeneron Pharmaceuticals are best-in-class in biotech.

3 Reasons Why Celgene Corp.'s Stock Dropped 15% in January

Celgene took a bath in January, and not just because the market was shying away from all things biotech.

Gilead: One Thing The Market Is Forgetting

Rebound For Big Biotech ETF Will Require Some Patience

Defense Wins Championships

The Key Takeaways From Alexion Pharmaceuticals Inc.'s Earnings Release

Alexion Pharmaceuticals released its fourth-quarter and full-year earnings earlier today. Here are the key numbers that investors need to know.

See More IBB News...

IBB's Top Competitors

IBB $244.04 (-2.36%)
Current stock: IBB
VTA $9.70 (-0.72%)
Current stock: VTA
NCV $4.52 (-1.31%)
Current stock: NCV
ZTR $10.73 (-0.83%)
Current stock: ZTR